BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12011822)

  • 1. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans.
    Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B
    Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
    Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
    Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
    Becker RC; Alexander JH; Newby LK; Yang H; Barrett Y; Mohan P; Wang J; Harrington RA; Wallentin LC
    Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation.
    Leitner JM; Jilma B; Mayr FB; Cardona F; Spiel AO; Firbas C; Rathgen K; Stähle H; Schühly U; Graefe-Mody EU
    Clin Pharmacol Ther; 2007 Jun; 81(6):858-66. PubMed ID: 17410124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
    Asero R; Tedeschi A; Coppola R; Griffini S; Paparella P; Riboldi P; Marzano AV; Fanoni D; Cugno M
    J Allergy Clin Immunol; 2007 Mar; 119(3):705-10. PubMed ID: 17204316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
    Pernerstorfer T; Stohlawetz P; Hollenstein U; Dzirlo L; Eichler HG; Kapiotis S; Jilma B; Speiser W
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2517-23. PubMed ID: 10521382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
    Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
    Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
    Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
    Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon.
    Bouchama A; Al-Mohanna F; Assad L; Baturcam E; Eldali A; Owaidah T; Dehbi M
    Crit Care Med; 2012 Apr; 40(4):1229-36. PubMed ID: 22080642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
    J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.